- Title
- Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240)
- Creators
- R. T. Penson (Author)H. Q. Huang (Author)L. B. Wenzel (Author)Bradley J. Monk (Author) - Creighton UniversityS. Stockman (Author)H. J.,3rd Long (Author)L. M. Ramondetta (Author)L. M. Landrum (Author)A. Oaknin (Author)T. J. Reid (Author)M. M. Leitao (Author)M. Method (Author)H. Michael (Author)K. S. Tewari (Author)
- Additional links
- http://doi.org/10.1016/S1470-2045(15)70004-5
- Publication Details
- Lancet Oncology, Vol.16(3), pp.301-311
- Publisher
- Elsevier Ltd
- Number of pages
- 301-311
- Identifiers
- 991005931657402656
- Academic Unit
- School of Medicine; Obstetrics & Gynecology; General Medicine
- Language
- English
- Resource Type
- Journal article
Journal article
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240)
Lancet Oncology, Vol.16(3), pp.301-311
03/2015
PMID: 25638326
Metrics
4 Record Views